Gene · 5921
Papers3,549
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,549
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Multilayer Architecture towards the Development and Distribution of Multimodal Interface Applications on the Edge. | Sensors (Basel) | 2024 | 39204892 | PubTator, text mining | PubMed |
| A Novel Autosomal Recessive Candidate Gene Responsible for RASopathy-Like Phenotype and Bone Marrow Failure: RASA3. | J Pediatr Genet | 2024 | 39086443 | PubTator, text mining | PubMed |
| Ras suppression potentiates rear actomyosin contractility-driven cell polarization and migration. | Nat Cell Biol | 2024 | 38951708 | PubTator, text mining | PubMed |
| Another face of RASA1: Report of familial germline variant in RASA1 with dysmorphic features. | Am J Med Genet A | 2024 | 38934655 | PubTator, text mining | PubMed |
| Bimodality in Ras signaling originates from processivity of the Ras activator SOS without deterministic bistability. | Sci Adv | 2024 | 38905351 | PubTator, text mining | PubMed |
| An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implications. | Cell Death Differ | 2024 | 38902547 | PubTator, text mining | PubMed |
| K128 ubiquitination constrains RAS activity by expanding its binding interface with GAP proteins. | EMBO J | 2024 | 38858602 | PubTator, text mining | PubMed |
A proteomics approach to isolating neuropilin-dependent α5 integrin trafficking pathways: neuropilin 1 and 2 co-traffic α5 integrin through endosomal p120RasGAP to promote polarised fibronectin fibrillogenesis in endothelial cells. | Commun Biol | 2024 | 38789481 | PubTator, text mining | PubMed |
| Unveiling heterogeneity in MSCs: exploring marker-based strategies for defining MSC subpopulations. | J Transl Med | 2024 | 38750573 | PubTator, text mining | PubMed |
| SHP2-EGFR States in Dephosphorylation Can Inform Selective SHP2 Inhibitors, Dampening RasGAP Action. | J Phys Chem B | 2024 | 38747619 | PubTator, text mining | PubMed |
| Genomic regions, candidate genes, and pleiotropic variants associated with physiological and anatomical indicators of heat stress response in lactating sows. | BMC Genomics | 2024 | 38741036 | PubTator, text mining | PubMed |
| Association of uncertain significance genetic variants with myocardial mechanics and morphometrics in patients with nonischemic dilated cardiomyopathy. | BMC Cardiovasc Disord | 2024 | 38664609 | PubTator, text mining | PubMed |
| Research progress on optimization of in vitro isolation, cultivation and preservation methods of dental pulp stem cells for clinical application. | Front Bioeng Biotechnol | 2024 | 38633667 | PubTator, text mining | PubMed |
| Genetically encodable biosensors for Ras activity. | RSC Chem Biol | 2024 | 38576721 | PubTator, text mining | PubMed |
| Single dominant lesion in capillary malformation-arteriovenous malformation (CM-AVM) RASA1 syndrome. | Pediatr Dermatol | 2024 | 38556785 | PubTator, text mining | PubMed |
| Activation of MAP Kinase Pathway by Polyisoprenylated Cysteinyl Amide Inhibitors Causes Apoptosis and Disrupts Breast Cancer Cell Invasion. | Biomedicines | 2024 | 38540084 | PubTator, text mining | PubMed |
| Retraction: RASA1 inhibits the progression of renal cell carcinoma by decreasing the expression of miR-223-3p and promoting the expression of FBXW7. | Biosci Rep | 2024 | 38516709 | PubTator, text mining | PubMed |
| Nigella sativa, Anthemis hyaline and Citrus sinensis extracts reduce SARS-CoV-2 replication by fluctuating Rho GTPase, PI3K-AKT, and MAPK/ERK pathways in HeLa-CEACAM1a cells. | Gene | 2024 | 38485035 | PubTator, text mining | PubMed |
| The role of microRNAs in understanding sex-based differences in Alzheimer's disease. | Biol Sex Differ | 2024 | 38297404 | PubTator, text mining | PubMed |
| Methodological choices in size and density fractionation of soil carbon reserves - A case study on wood fiber sludge amended soils. | Heliyon | 2024 | 38293545 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5921/papers?page=7